ker so pri zdravilih za ljudi merila kakovosti, varnosti in učinkovitosti v znatni meri usklajena z direktivo Sveta 65/65/EGS z dne 26. januarja 1965 o približevanju določb zakonov ali drugih predpisov, ki se nanašajo na zdravila fn ugo direktivo Sveta 75/319/EGS z dne 20. maja 1975 o približevanju določb zakonov in drugih predpisov, ki se nanašajo na lastniška zdravila fn rektivo Sveta 75/318/EGS z dne 20. maja 1975 o približevanju zakonodaje držav članic v zvezi z analiznimi farmakološko-toksikološkimi in kliničnimi standardi in protokoli, ki se nanašajo na preskušanje zdravil za uporabo v veterini fn
Whereas, in the case of medicinal products for human use, the criteria of quality, safety and efficacy have been extensively harmonized by Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products (5), and the Second Council Directive 75/319/EEC of 20 May 1975 on the approximation of provisions laid down by law, regulation and administrative action relating to proprietary medicinal products (6), and by Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of the Member States relating to analytical pharmaco-toxicological and clinical standards and protocols in respect of the testing of medicinal products (7);